| |
|
|
|
Genmark Diagnostics  
|
|
9.14 -0.465 (-0.05%) |
06-05 16:00 |
|
Open: |
9.54 |
Pre close: |
9.605 |
Target:
|
13.52
|
|
High: |
10.05 |
Low: |
9.06 |
Resistance:
|
11.57
13.49
|
|
Volume: |
1,415,808 |
Market Cap: |
642M |
Support:
|
8.47
7.05
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
9.57
 |
MACD |
MACD(12,26):
|
-0.09 |
|
MA(20): |
10.44 |
Signal(12,26,9): |
0.16 |
|
MA(100): |
6.83  |
Stochastic Oscillator |
%K(14,3):
|
24.39 |
|
MA(250): |
6.28 |
%D(3): |
26.49 |
|
Average Volume(K) |
3-Month: |
335528
|
52-Week |
High:
|
13.49 |
|
10-Days: |
162106 |
Low: |
3.36 |
|
RSI |
RSI(14):
|
42.88 |
Change(%): |
33.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.720 |
Return on Equity (ttm) |
-225.8 |
Shares Out. (M) |
70.23 |
|
EPS Est. Current Year |
-1.070 |
Return on Assets (ttm) |
-18.9 |
Shares Float (M) |
59.06 |
|
EPS Est. Next Year |
-0.690 |
PEG Ratio |
0.00 |
% Held by Insiders |
4.70 |
|
EPS Est. Next Quarter |
-0.140 |
Qtrly Rev. Growth |
79.9 |
% Held by Institutions |
91.80 |
|
Forward EPS |
-0.820 |
Gross Profit (p.s.) |
0.407 |
Shares Short (K) |
3750 |
|
Book Value (p.s.) |
0.210 |
EBITDA (p.s.) |
-0.355 |
P/E |
-12.69 |
|
Sales Per Share |
1.498 |
Qtrly Earnings Growth |
0.00 |
P/BV |
43.52 |
|
Profit Margin |
-40.18 |
Operating Cash Flow
(M) |
-34.35 |
P/S |
6.10 |
|
Operating Margin |
-29.86 |
Levered Free Cash Flow
(M) |
-12.89 |
P/CF |
-18.69 |
|
|
|
|
|
|
